Immunotherapy in renal cell carcinoma: latest evidence and clinical implications

Advances in understanding the mechanisms of tumour-induced immunosuppression have led to the development of immune-checkpoint inhibitors in cancer patients, including those with renal cell carcinoma (RCC). The optimal combination between immunotherapy and targeted agents (as well as the possible fav...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoni, Matteo, Massari, Francesco, Di Nunno, Vincenzo, Conti, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Montironi, Rodolfo, Cheng, Liang, Battelli, Nicola, Lopez-Beltran, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992965/
https://www.ncbi.nlm.nih.gov/pubmed/29899754
http://dx.doi.org/10.7573/dic.212528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992965/
https://www.ncbi.nlm.nih.gov/pubmed/29899754
http://dx.doi.org/10.7573/dic.212528

Ejemplares similares